Jean-Pierre Bizzari

Jean-Pierre Bizzari, MD is a world­renowned oncology expert who served as Executive Vice-President, Group Head, and Clinical Oncology Development (U.S., Europe, and Asia/Japan) at Celgene from 2008 to 2015. Before that Jean Pierre was head of clinical development in RPR­Aventis and Sanofi. Some of the drugs he has developed are - Taxotere, cpt-11, oxaliplatin, abraxan, revlimid, vidaza.
He is an active board member in various biotech companies and a member of the Scientific Advisory Board of the French National Cancer Institute (INCa) and European Organization of Research and Treatment of Cancer (EORTC).